FURMONERTINIB

Clinical trials for FURMONERTINIB explained in plain language.

Never miss a new study

Get alerted when new FURMONERTINIB trials appear

Sign up with your email to follow new studies for FURMONERTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New combo targets lung cancer brain tumors in 60-patient trial

Disease control Not yet recruiting

This study tests whether a higher dose of furmonertinib alone works better than a standard dose combined with chemotherapy for people with a specific type of lung cancer (EGFR-mutated) that has spread to the brain. About 60 adults who have not had prior treatment will be enrolled…

Matched conditions: FURMONERTINIB

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:14 UTC

FURMONERTINIB

Get alerted when new FURMONERTINIB trials appear

New combo targets lung cancer brain tumors in 60-patient trial